Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Bullboard Posts
Post by dimar66on Mar 12, 2011 4:26pm
422 Views
Post# 18275992

Is 3M the problem?

Is 3M the problem?Revenues decreased in all areas.
clinical                     -5%
biodefense          -14%
vector (WNV)      -62%
contract service  -80%
The decrease in clinical was probably due to 3M infectious disease, this would make the cardiac tests the best sales opportunity,  So what is happening with 3M are they selling anything at all, flu or RSV ??
Bullboard Posts